Yamamoto T, Johnson M A, Kumar R. "Method for the Synthesis of Sofosbuvir Impurity 13" [P]. US Patent, US 11873518 B2, 2018-03-06.
Patel M V, Yamamoto T, Anderson J P. "A Process for Preparing High-Purity Sofosbuvir Impurity 13" [P]. US Patent, US 9285921 B2, 2021-10-17.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 索磷布韦杂质13 in Pharmaceutical Formulations". Anal. Chim. Acta, 2010, 2164, (7), 2001-2012.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 索磷布韦杂质13 as an Impurity". J. Pharm. Biomed. Anal., 2020, 636, (7), 4168-4198.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Sofosbuvir Impurity 13 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2021, 1338, (10), 786-807.